Adaptin Bio (APTN) Long-Term Deferred Tax (2022 - 2024)
Adaptin Bio (APTN) posted Long-Term Deferred Tax of $193876.0 for Q4 2024, up 138.37% sequentially from $81335.0 in Q4 2023, and up 138.37% YoY from $81335.0 in Q1 2024.
Adaptin Bio (APTN) Long-Term Deferred Tax (2022 - 2024) Analysis & Trends
Adaptin Bio has reported Long-Term Deferred Tax for 3 years, with the latest figure at $193876.0 in Q4 2024.
- Quarterly Long-Term Deferred Tax rose 138.37% year-over-year to $193876.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $193876.0 (up 138.37% YoY) and the FY2024 annual result came in at $193876.0, up 138.37% from the prior year.
- Long-Term Deferred Tax rose to $193876.0 in Q4 2024 per APTN's latest filing, from $81335.0 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $193876.0 in Q4 2024 and troughed at $27804.0 in Q4 2022.
- A 3-year average of $101005.0 and a median of $81335.0 in 2023 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax jumped 192.53% in 2023, then soared 138.37% in 2024.
- Over 3 years, Long-Term Deferred Tax stood at $27804.0 in 2022, then surged by 192.53% to $81335.0 in 2023, then jumped by 138.37% to $193876.0 in 2024.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $193876.0, $81335.0, and $27804.0 for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 193,876.00 |
| Dec 31, 2023 | 81,335.00 |
| Dec 31, 2022 | 27,804.00 |